Retinal degenerative diseases pose a serious threat to eye health, but there is currently no effective treatment available. Recent years have witnessed rapid development of several cutting-edge technologies, such as gene therapy, stem cell therapy, and tissue engineering. Due to the special features of ocular structure, some of these technologies have been translated into ophthalmological clinic practice with fruitful achievements, setting a good example for other fields. This paper reviews the development of the gene and stem cell therapies in ophthalmology
Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment epithelium ...
Stem cells are currently one of the most researched and explored subject in science. They consstitue...
Gene therapy, in its current form, seems to be a promising treatment option for almost all ocular di...
Over the last few years, huge progress has been made with regard to the understanding of molecular m...
Gene therapy is a novel form of drug delivery that enlists the synthetic machinery of the patient&#x...
Sight restoration after retinal degeneration still represents an unmet goal. Since therapeutic strat...
Sustenance of visual function is the ultimate focus of ophthalmologists. Failure of complete recover...
The development of technology and a modern research approach in the 21st century has enabled access ...
International audienceRetinal degenerative diseases are a leading cause of irreversible blindness. R...
Background: Gene therapy represents the therapeutic delivery of nucleic acid polymers into patient c...
Many clinical trials using gene therapy have shown significant therapeutic benefits and exceptional ...
There is an impelling need to develop effective therapeutic strategies for patients with retinal dis...
Abstract Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment ep...
Stem cells are undifferentiated cells which have the ability to self-renew and differentiate into ma...
Abstract Degenerative retinal disease leads to significant visual morbidity worldwide. Diabetic reti...
Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment epithelium ...
Stem cells are currently one of the most researched and explored subject in science. They consstitue...
Gene therapy, in its current form, seems to be a promising treatment option for almost all ocular di...
Over the last few years, huge progress has been made with regard to the understanding of molecular m...
Gene therapy is a novel form of drug delivery that enlists the synthetic machinery of the patient&#x...
Sight restoration after retinal degeneration still represents an unmet goal. Since therapeutic strat...
Sustenance of visual function is the ultimate focus of ophthalmologists. Failure of complete recover...
The development of technology and a modern research approach in the 21st century has enabled access ...
International audienceRetinal degenerative diseases are a leading cause of irreversible blindness. R...
Background: Gene therapy represents the therapeutic delivery of nucleic acid polymers into patient c...
Many clinical trials using gene therapy have shown significant therapeutic benefits and exceptional ...
There is an impelling need to develop effective therapeutic strategies for patients with retinal dis...
Abstract Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment ep...
Stem cells are undifferentiated cells which have the ability to self-renew and differentiate into ma...
Abstract Degenerative retinal disease leads to significant visual morbidity worldwide. Diabetic reti...
Retinal degenerative diseases that target photoreceptors or the adjacent retinal pigment epithelium ...
Stem cells are currently one of the most researched and explored subject in science. They consstitue...
Gene therapy, in its current form, seems to be a promising treatment option for almost all ocular di...